NeoDynamics appoints Matthew Colpoys, to lead US operations
NeoDynamics AB (Nasdaq First North Growth Market Stockholm: NEOD.ST), a medical device company dedicated to advancing the diagnosis and care of cancer, today announced the appointment of current board member Matt Colpoys as head of the company’s US subsidiary. Colpoys will remain on the board and will report to CEO Anna Eriksrud.“Matt is an experienced executive with an extensive background in new product launches, commercialization and corporate finance. He has also guided international companies in US launch efforts in the past – a perfect fit for NeoDynamics as we move quickly to